Integer Holdings (ITGR) Income from Continuing Operations (2010 - 2026)

Integer Holdings (ITGR) reported Income from Continuing Operations of 16506000.0 for Q2 2026, up 173.47% on a YoY basis from 6035667.85 in Q2 2025, and down 66.04% sequentially from 48608000.0 in Q4 2025.

Integer Holdings (ITGR) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Integer Holdings (ITGR) has 17 years of Income from Continuing Operations data on file, last reported at 16506000.0 in Q2 2026.

  • For the quarter ending Q2 2026, Income from Continuing Operations rose 173.47% year-over-year to 16506000.0; the trailing twelve-month figure through Apr 2026 stood at 141801000.0 (up 81.8% YoY), and the FY2025 full-year result was 102830000.0, down 15.05% from the prior year.
  • Income from Continuing Operations retreated to 16506000.0 in Q2 2026, from 48608000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 48608000.0 in Q4 2025 to a low of 22465000.0 in Q1 2025.
  • A 5-year average of 23063647.06 and a median of 23971000.0 in 2023 frame the typical range for Income from Continuing Operations.
  • Across the five-year window, Income from Continuing Operations slumped 209.1% in 2025 and soared 173.47% in 2026, its largest moves.
  • Tracing ITGR's Income from Continuing Operations over 5 years: stood at 11453000.0 in 2022, then surged by 134.11% to 26813000.0 in 2023, then advanced by 22.97% to 32973000.0 in 2024, then surged by 47.42% to 48608000.0 in 2025, then tumbled by 66.04% to 16506000.0 in 2026.
  • Business Quant data shows ITGR's Income from Continuing Operations at 16506000.0 in Q2 2026, 48608000.0 in Q4 2025, and 39678000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Integer Holdings 3.34 Bn 3.33 Bn 109.60 Mn 16.51 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 16.51 Mn
Dec 31, 2025 48.61 Mn
Sep 26, 2025 39.68 Mn
Jun 27, 2025 37.01 Mn
Mar 28, 2025 -22.47 Mn
Dec 31, 2024 32.97 Mn
Sep 27, 2024 36.28 Mn
Jun 28, 2024 31.21 Mn
Mar 29, 2024 20.59 Mn
Dec 31, 2023 26.81 Mn
Sep 29, 2023 28.17 Mn
Jun 30, 2023 23.97 Mn
Mar 31, 2023 13.07 Mn
Dec 31, 2022 11.45 Mn
Sep 30, 2022 16.06 Mn
Jul 1, 2022 20.84 Mn
Apr 1, 2022 11.32 Mn
Dec 31, 2021 20.04 Mn
Oct 1, 2021 22.09 Mn
Jul 2, 2021 29.43 Mn